{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:00:43Z","timestamp":1763978443704,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["CY2021-QN-B08"],"award-info":[{"award-number":["CY2021-QN-B08"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371914"],"award-info":[{"award-number":["82371914"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["21JR7RA427"],"award-info":[{"award-number":["21JR7RA427"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","academicradiology.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.acra.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T19:52:23Z","timestamp":1723837943000},"page":"460-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting Durable Clinical Benefits of Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer: A\u00a0Nomogram Based on CT Imaging and Immune Type"],"prefix":"10.1016","volume":"32","author":[{"given":"Liangna","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaibo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyuan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8109-6347","authenticated-orcid":false,"given":"Junlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.acra.2024.07.004_bib1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jtho.2019.03.022","article-title":"Advanced-stage non-small cell lung cancer: advances in thoracic oncology 2018","volume":"14","author":"Remon","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.acra.2024.07.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102227","article-title":"Turning tumors from cold to inflamed to improve immunotherapy response","volume":"101","author":"Gerard","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"10.1016\/j.acra.2024.07.004_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41573-022-00493-5","article-title":"Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities","volume":"21","author":"Kim","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"10212","key":"10.1016\/j.acra.2024.07.004_bib5","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.acra.2024.07.004_bib6","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/cam4.1243","article-title":"Prognostic value of PD-L1 expression in combination with CD8(+) TILs density in patients with surgically resected non-small cell lung cancer","volume":"7","author":"Yang","year":"2018","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.acra.2024.07.004_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.2018180431","article-title":"Lung adenocarcinoma: CT features associated with spread through air spaces","volume":"289","author":"Kim","year":"2018","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.acra.2024.07.004_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.2015151120","article-title":"Pleural tags on CT scans to predict visceral pleural invasion of non-small cell lung cancer that does not abut the pleura","volume":"279","author":"Hsu","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2024.07.004_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.radonc.2020.07.030","article-title":"Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis","volume":"151","author":"van Laar","year":"2020","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2214\/AJR.17.18167","article-title":"Adverse prognostic CT findings for patients with advanced lung adenocarcinoma receiving first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy","volume":"210","author":"Chang","year":"2018","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2290790","article-title":"Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases","volume":"13","author":"Li","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.acra.2024.07.004_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2015.11.020","article-title":"Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy","volume":"55","author":"Tokito","year":"2016","journal-title":"Eur J Cancer"},{"issue":"6190","key":"10.1016\/j.acra.2024.07.004_bib14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40364-024-00560-6","article-title":"MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark Res"},{"issue":"9","key":"10.1016\/j.acra.2024.07.004_bib16","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12967-022-03688-x","article-title":"Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer","volume":"20","author":"Su","year":"2022","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.acra.2024.07.004_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/1759-7714.13352","article-title":"Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas","volume":"11","author":"Yoon","year":"2020","journal-title":"Thorac Cancer"},{"issue":"4","key":"10.1016\/j.acra.2024.07.004_bib19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00261-024-04200-3","article-title":"Correlation of CT parameters and PD-L1 expression status in gastric cancer","volume":"49","author":"Xu","year":"2024","journal-title":"Abdom Radiol"},{"issue":"5","key":"10.1016\/j.acra.2024.07.004_bib20","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.acra.2023.10.049","article-title":"Vasari-based features nomogram to predict the tumor-infiltrating CD8+ T cell levels in glioblastoma","volume":"31","author":"Xue","year":"2024","journal-title":"Acad Radiol"},{"issue":"6","key":"10.1016\/j.acra.2024.07.004_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/JCO.21.01589","article-title":"Preoperative and postoperative systemic therapy for operable non-small-cell lung cancer","volume":"40","author":"Chaft","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14737140.2018.1409624","article-title":"Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer","volume":"18","author":"Nagasaka","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"11","key":"10.1016\/j.acra.2024.07.004_bib23","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying cancers based on T-cell infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.acra.2024.07.004_bib24","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1158\/1078-0432.CCR-14-1905","article-title":"Stromal CD8+ T-cell density\u2014a promising supplement to TNM staging in non-small cell lung cancer","volume":"21","author":"Donnem","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/0366-6999.147828","article-title":"Prognostic significance of tumor-infiltrating CD8\u207a or CD3\u207a T lymphocytes and interleukin-2 expression in radically resected non-small cell lung cancer","volume":"128","author":"Tian","year":"2015","journal-title":"Chin Med J"},{"key":"10.1016\/j.acra.2024.07.004_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4180517","article-title":"PD-L1 expression and CD8(+) T cell infiltration predict a favorable prognosis in advanced gastric cancer","volume":"2018","author":"Wang","year":"2018","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.acra.2024.07.004_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000458412","article-title":"Impact of PD-L1 expression in patients with surgically resected non-small-cell lung cancer","volume":"92","author":"Igawa","year":"2017","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/modpathol.2017.111","article-title":"Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases","volume":"31","author":"Keller","year":"2018","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.acra.2024.07.004_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.21037\/tlcr.2019.08.04","article-title":"The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients","volume":"8","author":"Li","year":"2019","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"10.1016\/j.acra.2024.07.004_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/vaccines8020202","article-title":"CD8(+) tumour-infiltrating lymphocytes and tumour microenvironment immune types as biomarkers for immunotherapy in sinonasal intestinal-type adenocarcinoma","volume":"8","author":"Garc\u00eda-Mar\u00edn","year":"2020","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.acra.2024.07.004_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","article-title":"The international association for the study of lung cancer lung cancer staging project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer","volume":"19","author":"Rami-Porta","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.acra.2024.07.004_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.mpa.0000188305.90290.50","article-title":"Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome","volume":"32","author":"Fogar","year":"2006","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.acra.2024.07.004_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00595-016-1433-2","article-title":"The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer","volume":"47","author":"Iseki","year":"2017","journal-title":"Surg Today"},{"issue":"5","key":"10.1016\/j.acra.2024.07.004_bib34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.acra.2024.07.004_bib35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.breast.2011.11.002","article-title":"Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy","volume":"21","author":"Vicente Conesa","year":"2012","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.acra.2024.07.004_bib36","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.amjmed.2022.04.017","article-title":"Malignant pleural effusion: presentation, diagnosis, and management","volume":"135","author":"Gayen","year":"2022","journal-title":"Am J Med"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224004392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224004392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T01:59:53Z","timestamp":1737079193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633224004392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1076633224004392"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2024.07.004","relation":{},"ISSN":["1076-6332"],"issn-type":[{"type":"print","value":"1076-6332"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Durable Clinical Benefits of Postoperative Adjuvant Chemotherapy in Non-small Cell Lung Cancer: A\u00a0Nomogram Based on CT Imaging and Immune Type","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Association of University Radiologists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}